World Health Organization Announces Two New Candidate Vaccines To Join Ebola Trial; Two Vaccine Candidates Are Chadox1, Developed By The University Of Oxford With The Serum Institute Of India, And Moderna’s MRNA-1469; Recommended Adding Two New Ebola Vaccine Candidates To Ongoing Tumaini Clinical Trial In Democratic Republic Of Congo; Initial Findings From Treatment Trials Are Expected In Coming Months, With Results From Vaccine Trial Expected In Early 2027